Generic Name |
Nivolumab | |
---|---|---|
IND |
BMS-936558 | |
Brand Name (US) |
Opdivo | |
Manufacturer |
Bristol-Myers Squibb | |
Drug Type |
||
Delivery |
Intravenous | |
Approval Status |
Approved for a non-GIST cancer | |
Indications |
||
Overall Strategy |
Immune system | |
Strategy |
Immunotherapy | |
Drug Category |
PD-1 Inhibitor |
Links |
|
Trials of this drug |
|
Trial results |